How to shift to single-use assemblies to protect complex drug products
This white paper by Entegris outlines what you should consider when choosing a vendor partner to safeguard your products
Add bookmark
As novel therapies produced and stored under extreme conditions become more common, containers that have been in use for decades are increasingly unable to meet project needs and regulatory standards.
This whitepaper by Entegris explains how new single-layer assemblies made with more robust materials may offer companies a safer and more efficient solution, and outlines how you can choose the best partner for your sterility and validation needs.
Download this white paper to find out:
- The five considerations pharma companies must take into account for materials validation
- Choosing the right equipment for therapies that require storage at extreme temperatures
- Why shifting from traditional equipment to single-use assemblies provides flexibility and efficiency
Sponsored By:
